Publication | Closed Access

Effects of Telmisartan Added to Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Hemodialysis Patients With Chronic Heart Failure

HemodialysisHeart FailureHypertensionChronic Heart FailureCardiovascular DiseaseHemodialysis PatientsMedicineAntihypertensive TherapyRenal FunctionPharmacologyCardiovascular PharmacologyDialysis TherapyPharmacotherapyChronic Kidney DiseaseTelmisartan Added